TABLE 4.
Antibiotic-strain combination | Phenotypeb | Strain no. | FIC index for amikacin-fosfomycin (5:2) plus comparator agentc | Time-kill kinetics result |
|
---|---|---|---|---|---|
Log10 reduction in CFU/ml at 24 hd | Interpretive category | ||||
For Gram-negative bacteria | |||||
Aztreonam | |||||
E. cloacae | AmpC | 5686 | 0.5 | 1.7 | Indifference |
P. aeruginosa | Wild type | ATCC 27853 | 0.5 | 2.1 | Synergy |
Cefepime | |||||
E. cloacae | AmpC | 5686 | 0.375 | <0.5 | Indifference |
E. coli | Wild type | ATCC 25922 | 0.5 | >8 | Synergy |
Gentamicin–Acinetobacter sp. | MDR | 8133 | 0.5 | 0.2 increase | Indifference |
Meropenem | |||||
Acinetobacter sp. | MDR | 1986 | 0.5 | 0.8 | Indifference |
E. cloacae | AmpC | 5686 | 0.5 | 1.3 | Indifference |
K. pneumoniae | KPC | 25 | 0.375 | ND | |
For Gram-positive bacteria | |||||
Azithromycin–S. aureus | MSSA | ATCC 29213 | 0.5 | 3.0 | Synergy |
Daptomycin–E. faecalis | Wild type | ATCC 29212 | 0.5 | 2.7 | Synergy |
Defined as a FIC index of ≤0.5.
AmpC, AmpC type β-lactamase; KPC, Klebsiella pneumoniae carbapenemase; MDR, multidrug resistant.
Determined by checkerboard synergy testing.
ND, not determined.